A new analysis summarizes a decade of research on the effects of a psychedelic brew on anxiety and trauma responses. With the ...

Neushen Therapeutics Inc. has synthesized 5-HT2A receptor agonists reported to be useful for the treatment of depression, schizophrenia, anxiety and post-traumatic stress disorder.

One of these is the 5-HT2A receptor, which has a recently discovered unique characteristic: It dampens incoming visual information, giving our brain more space for internal processes and ...

A comprehensive review published in Psychedelics examines the current understanding of how ayahuasca, a traditional Amazonian ...

New research explores how ayahuasca influences brain circuits involved in fear and anxiety, offering insights into its potential therapeutic uses ...

We propose a multi-site, double-blind, randomized clinical trial of the 5-HT2A receptor agonist psilocybin for smoking cessation. A diverse sample with regard to ethnoracial identity and SES will be ...

Explore ayahuasca's effects on anxiety, memory, and emotional processing, revealing its therapeutic potential for ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.